GLP-1 receptor agonist is named as a drug or biological intervention in 3 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Peking University Third Hospital (2) and Chinese University of Hong Kong (1). Registered phases: Not applicable and Phase 2. Conditions studied include Obesity; Infertility, Female; Polycystic Ovary Syndrome (PCOS).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05356104 | GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) (ClinicalTrials.gov ↗) Cerebral Small Vessel Disease |
Phase 2 | Recruiting |
| NCT06775093 | Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity (ClinicalTrials.gov ↗) Polycystic Ovary Syndrome, Obesity, Infertility, Female |
Not applicable | Not yet open |
| NCT07687667 | Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS (ClinicalTrials.gov ↗) Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Obesity | 2 |
| Infertility, Female | 2 |
| Polycystic Ovary Syndrome (PCOS) | 1 |
| Polycystic Ovary Syndrome | 1 |
| Cerebral Small Vessel Disease | 1 |
| Lead sponsor | Trials |
|---|---|
| Peking University Third Hospital | 2 |
| Chinese University of Hong Kong | 1 |
| Register | GLP-1 receptor agonist trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how GLP-1 receptor agonist works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists GLP-1 receptor agonist (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.